Non-Hodgkin's lymphomas in the Middle East. A study of 417 patients with emphasis on special features
β Scribed by Philip Salem; Elias Anaissie; Charles Allam; Sima Geha; Labib Hashimi; Nuhad Ibrahim; Joseph Jabbour; Nassir Habboubi; Maryse Khalyl
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 498 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This study compared the resting energy expenditure (REE) modifications observed during successive intensive identical chemotherapy courses in non-Hodgkin's lymphoma patients to assess indirectly the metabolic changes induced by the cytotoxic effect of drugs on the tumor. With this therapeutic regime
## Background: The precise incidence of familial hodgkin disease (hd) and non-hodgkin lymphoma (nhl) in first-degree relatives is unknown. through record linkage using two population-based sources, the authors estimated the risk of hd and nhl in family members of lymphoma probands. ## Methods: Th
## Background: Chemotherapy containing anthracycline is the standard initial treatment for aggressive non-hodgkin's lymphoma (nhl), and the international prognostic index (ipi) is widely accepted as the standard tool for determining the prognosis of patients with this disease. however, the data on
Blood lymphocytes from 20 untreated patients with Hodgkin's disease were compared with those of 20 untreated patients with non-Hodgkin's lymphoma with regard to the responsiveness of the cells to PHA and ConA following exposure to varying doses of ionizing radiation in vitro. Lymphocytes from 19 of